M&A · Healthcare · Pharmaceutical Preparations
Novartis AG to acquire MorphoSys AG
Announced Jun 20, 2024 · Closed Jul 25, 2024
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Novartis AG (NVS)
- Target
- MorphoSys AG (MPSYF)
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jul 25, 2024
Deal protections
Not yet read from the merger agreement.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Sector context · Healthcare
- Comparable deals
- 109 in the prior 24 months
- Premium
- Sector median 63.0%
- EV / Adj. EBITDA
- Sector median 17.2x
- Break fee
- Sector median 3.5%
Timeline
- AnnouncedJun 20, 2024
- Tender offerJul 5, 2024
- ClosedJul 25, 2024